Bladder Cancer Market Research Reports

RSS Sort By :
TITLE Price Buy Now More options

DelveInsight “Bladder cancer - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Bladder cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and...

$ 2750


DelveInsight’s “Bladder cancer - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Bladder cancer - Market Insi...

$ 5750


This report studies the global Bladder Cancer Therapeutics market, analyzes and researches the Bladder Cancer Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top pl...

$ 3300


Increase in usage of biotechnological technologies in the development of anticancer drugs such as immunotherapies or monoclonal antibodies, adoptive-cell therapies, and new vaccines is an emerging trend in this market. Major competitors such as Roche...

$ 4000


In this report, we analyze the Superficial Bladder Cancer Drugs industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of i...

$ 2600


Bladder Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H1 2017, provides an overview of the Bladder Cancer ...

$ 2000


The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary sys...

$ 3500


Bladder Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bladder Cancer clinical trials scenario. Thi...

$ 2500


Bladder cancer is a urologic malignancy arising primarily from epithelial cells lining the bladder. In the vast majority of cases (>90%), bladder cancer manifests as transitional (urothelial) cell carcinoma (TCC). The remaining cases manifest a...

$ 10995


This study focuses on China’s Bladder Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chi...

$ 1800


This study focuses on China’s Bladder Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consu...

$ 1800


China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the co...

$ 4000


Notes: Production, means the output of Superficial Bladder Cancer Drugs Revenue, means the sales value of Superficial Bladder Cancer Drugs This report studies Superficial Bladder Cancer Drugs in Global market, especially ...

$ 2900


Notes: Production, means the output of Superficial Bladder Cancer Drugs Revenue, means the sales value of Superficial Bladder Cancer Drugs This report studies Superficial Bladder Cancer Drugs in Global market, especially ...

$ 3500


Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide (Parkin, 2008; Ploeg et al., 2009). The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exp...

$ 3995


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2016, provides an overview of the Muscle Invasive Bladder Cancer (MIBC) (Oncology) pipeline landscape.M...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.Bladder cancer occurs in tissues of the urinary...

$ 2000


GlobalData's clinical trial report, "Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H2, 2016" provides an overview of Muscle Invasive Bladder Cancer (MIBC) clinical trials scenario. This report provides top line data relating...

$ 2500


Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline landscape.T...

$ 2000


The United States Non Muscle Invasive Bladder Cancer Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Non Muscle Invasive Bladder Cancer Drugs industry. The report provides a ba...

$ 3800

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: